Clinical Trials
6 trialsNCT02883062 2026-05-28
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT02326974 2026-04-17
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT02348684 2026-04-01
Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Medical College of Wisconsin
Completed
NCT01796197 2026-02-05
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00210236 2025-10-20
AXIL95
Institut Bergonié
Phase 3 Terminated
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed